These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 19555536)

  • 1. HAART and risk of tuberculosis in HIV-infected South African children: a multi-site retrospective cohort.
    Martinson NA; Moultrie H; van Niekerk R; Barry G; Coovadia A; Cotton M; Violari A; Gray GE; Chaisson RE; McIntyre JA; Meyers T
    Int J Tuberc Lung Dis; 2009 Jul; 13(7):862-7. PubMed ID: 19555536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.
    Golub JE; Pronyk P; Mohapi L; Thsabangu N; Moshabela M; Struthers H; Gray GE; McIntyre JA; Chaisson RE; Martinson NA
    AIDS; 2009 Mar; 23(5):631-6. PubMed ID: 19525621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001.
    Miranda A; Morgan M; Jamal L; Laserson K; Barreira D; Silva G; Santos J; Wells C; Paine P; Garrett D
    PLoS One; 2007 Sep; 2(9):e826. PubMed ID: 17786198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso.
    Dembélé M; Saleri N; Carvalho AC; Saouadogo T; Hien AD; Zabsonre I; Koala ST; Simporé J; Matteelli A
    Int J Tuberc Lung Dis; 2010 Mar; 14(3):318-23. PubMed ID: 20132623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of tuberculosis in HIV-infected patients receiving HAART: interaction between TST and CD4 count.
    Martín-Echevarria E; Rodríguez-Zapata M; Torralba M; Fernández JM; Moreno A; Casado JL; Dronda F; Pérez-Elías MJ; Navas E; Moreno S
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1347-52. PubMed ID: 22283893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of opportunistic infections after diagnosis of active tuberculosis in HIV-infected patients.
    Kwara A; Carter EJ; Rich JD; Flanigan TP
    AIDS Patient Care STDS; 2004 Jun; 18(6):341-7. PubMed ID: 15294084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort.
    Lawn SD; Badri M; Wood R
    AIDS; 2005 Dec; 19(18):2109-16. PubMed ID: 16284460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Ylitalo N; Brogly S; Hughes MD; Nachman S; Dankner W; Van Dyke R; Seage GR;
    Arch Pediatr Adolesc Med; 2006 Aug; 160(8):778-87. PubMed ID: 16894075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of highly active antiretroviral treatment with incident tuberculosis in people living with HIV/AIDS.
    Yen YF; Jen IA; Chuang PH; Chen M; Lan YC; Lee CY; Arthur Chen YM
    Ann Epidemiol; 2018 Dec; 28(12):886-892.e3. PubMed ID: 29656849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-HAART CD4+ T-lymphocytes as biomarkers of post-HAART immune recovery in HIV-infected children with or without TB co-infection.
    Gopalakrishnan V; Bose E; Nair U; Cheng Y; Ghebremichael M
    BMC Infect Dis; 2020 Oct; 20(1):756. PubMed ID: 33059622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of highly active antiretroviral treatment on TB incidence among HIV infected children and their clinical profile, retrospective cohort study, South West Ethiopia.
    Tiruneh F; Deyas Y
    Sci Rep; 2020 Dec; 10(1):21468. PubMed ID: 33293656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of tuberculosis in human immunodeficiency virus infected patients receiving antiretroviral therapy.
    Martín-Echevarria E; Serrano-Villar S; Sainz T; Moreno A; Casado JL; Dronda F; Elías MJ; Navas E; Zapata MR; Moreno S
    Int J Tuberc Lung Dis; 2014 Sep; 18(9):1080-4. PubMed ID: 25189556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High rates of tuberculosis in patients accessing HAART in rural South Africa.
    Naidoo K; Karim QA; Bhushan A; Naidoo K; Yende-Zuma N; McHunu PK; Frohlich J; Karim F; Upfold M; Kocheleff P; Abdool Karim SS
    J Acquir Immune Defic Syndr; 2014 Apr; 65(4):438-46. PubMed ID: 24256629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical burden of tuberculosis among human immunodeficiency virus-infected children in Western Kenya and the impact of combination antiretroviral treatment.
    Braitstein P; Nyandiko W; Vreeman R; Wools-Kaloustian K; Sang E; Musick B; Sidle J; Yiannoutsos C; Ayaya S; Carter EJ
    Pediatr Infect Dis J; 2009 Jul; 28(7):626-32. PubMed ID: 19451858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.
    Semu M; Fenta TG; Medhin G; Assefa D
    BMC Infect Dis; 2017 Jan; 17(1):5. PubMed ID: 28049455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of antiretrovirals in HIV-infected children in a tuberculosis prevention trial: IMPAACT P1041.
    Zeldow B; Kim S; McSherry G; Cotton MF; Jean-Philippe P; Violari A; Bobat R; Nachman S; Mofenson LM; Madhi SA; Mitchell C
    Int J Tuberc Lung Dis; 2017 Jan; 21(1):38-45. PubMed ID: 28157463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and associated factors of pulmonary tuberculosis in HIV-infected children after highly active antiretroviral therapy (HAART) in China: a retrospective study.
    Mu W; Zhao Y; Sun X; Ma Y; Yu L; Liu X; Zhao D; Dou Z; Fang H; Zhang F
    AIDS Care; 2014; 26(9):1127-35. PubMed ID: 24512621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study.
    Badri M; Wilson D; Wood R
    Lancet; 2002 Jun; 359(9323):2059-64. PubMed ID: 12086758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, risk factors and mortality of tuberculosis in Danish HIV patients 1995-2007.
    Taarnhøj GA; Engsig FN; Ravn P; Johansen IS; Larsen CS; Røge B; Andersen AB; Obel N
    BMC Pulm Med; 2011 May; 11():26. PubMed ID: 21605366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy.
    Karo B; Krause G; Castell S; Kollan C; Hamouda O; Haas W;
    BMC Infect Dis; 2017 Jul; 17(1):517. PubMed ID: 28743248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.